# Blackstone Secured Lending Fund: financial statements, quarterly

BXSL · NYSE · CIK 1736035 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bxsl.md) · [Financials](/companies/bxsl/financials.md) · [Filings](/companies/bxsl/filings.md) · [Insiders](/companies/bxsl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bxsl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [65.3](/filings/0001736035-24-000035.md) | [68.3 d](/filings/0001736035-26-000004.md) | [66.7](/filings/0001736035-25-000013.md) | [78.8](/filings/0001736035-25-000018.md) | [88.2](/filings/0001736035-25-000021.md) | [92.4 d](/filings/0001736035-26-000004.md) | [93.0](/filings/0001736035-26-000010.md) | [92.3](/filings/0001736035-26-000016.md) | [94.7](/filings/0001736035-25-000021.md) | [102 d](/filings/0001736035-26-000004.md) | [100](/filings/0001736035-26-000010.md) | [101](/filings/0001736035-26-000016.md) |
| Net income | $m | [171](/filings/0001736035-24-000035.md) | [157 d](/filings/0001736035-26-000004.md) | [184](/filings/0001736035-25-000013.md) | [196](/filings/0001736035-25-000018.md) | [152](/filings/0001736035-25-000021.md) | [162 d](/filings/0001736035-26-000004.md) | [150](/filings/0001736035-26-000010.md) | [155](/filings/0001736035-26-000016.md) | [132](/filings/0001736035-25-000021.md) | [126 d](/filings/0001736035-26-000004.md) | [25.2](/filings/0001736035-26-000010.md) | [9.5](/filings/0001736035-26-000016.md) |
| Diluted EPS | $ per share | [1.01](/filings/0001736035-24-000035.md) | not reported | [0.96](/filings/0001736035-25-000013.md) | [1.01](/filings/0001736035-25-000018.md) | [0.75](/filings/0001736035-25-000021.md) | not reported | [0.66](/filings/0001736035-26-000010.md) | [0.68](/filings/0001736035-26-000016.md) | [0.57](/filings/0001736035-25-000021.md) | not reported | [0.11](/filings/0001736035-26-000010.md) | [0.04](/filings/0001736035-26-000016.md) |
| Basic EPS | $ per share | [1.01](/filings/0001736035-24-000035.md) | not reported | [0.96](/filings/0001736035-25-000013.md) | [1.01](/filings/0001736035-25-000018.md) | [0.75](/filings/0001736035-25-000021.md) | not reported | [0.66](/filings/0001736035-26-000010.md) | [0.68](/filings/0001736035-26-000016.md) | [0.57](/filings/0001736035-25-000021.md) | not reported | [0.11](/filings/0001736035-26-000010.md) | [0.04](/filings/0001736035-26-000016.md) |

- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.1](/filings/0001736035-23-000023.md) | [0.2](/filings/0001736035-25-000008.md) | [0.1](/filings/0001736035-24-000017.md) | [0.3](/filings/0001736035-24-000026.md) | [0.2](/filings/0001736035-24-000035.md) | [0.2](/filings/0001736035-26-000004.md) | [1.0](/filings/0001736035-25-000013.md) | [0.3](/filings/0001736035-25-000018.md) | [0.2](/filings/0001736035-25-000021.md) | [0.3](/filings/0001736035-26-000016.md) | [0.4](/filings/0001736035-26-000010.md) | [0.3](/filings/0001736035-26-000016.md) |
| Total assets | $bn | [9.8](/filings/0001736035-23-000023.md) | [10.1](/filings/0001736035-25-000008.md) | [10.7](/filings/0001736035-24-000017.md) | [11.8](/filings/0001736035-24-000026.md) | [12.4](/filings/0001736035-24-000035.md) | [13.5](/filings/0001736035-26-000004.md) | [14.0](/filings/0001736035-25-000013.md) | [13.7](/filings/0001736035-25-000018.md) | [14.3](/filings/0001736035-25-000021.md) | [14.7](/filings/0001736035-26-000016.md) | [14.4](/filings/0001736035-26-000010.md) | [13.8](/filings/0001736035-26-000016.md) |
| Total liabilities | $bn | [5.2](/filings/0001736035-23-000023.md) | [5.2](/filings/0001736035-25-000008.md) | [5.5](/filings/0001736035-24-000017.md) | [6.4](/filings/0001736035-24-000026.md) | [6.7](/filings/0001736035-24-000035.md) | [7.4](/filings/0001736035-26-000004.md) | [7.7](/filings/0001736035-25-000013.md) | [7.4](/filings/0001736035-25-000018.md) | [8.0](/filings/0001736035-25-000021.md) | [8.4](/filings/0001736035-26-000016.md) | [8.3](/filings/0001736035-26-000010.md) | [7.8](/filings/0001736035-26-000016.md) |
| Long-term debt | $bn | [5.0](/filings/0001736035-23-000023.md) | [4.9](/filings/0001736035-25-000008.md) | [5.3](/filings/0001736035-24-000017.md) | [6.1](/filings/0001736035-24-000026.md) | [6.4](/filings/0001736035-24-000035.md) | [7.1](/filings/0001736035-26-000004.md) | [7.4](/filings/0001736035-25-000013.md) | [7.1](/filings/0001736035-25-000018.md) | [7.7](/filings/0001736035-25-000021.md) | [8.1](/filings/0001736035-26-000016.md) | [8.0](/filings/0001736035-26-000010.md) | [7.5](/filings/0001736035-26-000016.md) |
| Shareholders' equity | $bn | [4.6](/filings/0001736035-24-000035.md) | [5.0](/filings/0001736035-26-000004.md) | [5.2](/filings/0001736035-25-000018.md) | [5.4](/filings/0001736035-25-000021.md) | [5.7](/filings/0001736035-25-000021.md) | [6.1](/filings/0001736035-26-000016.md) | [6.2](/filings/0001736035-26-000016.md) | [6.3](/filings/0001736035-26-000016.md) | [6.3](/filings/0001736035-25-000021.md) | [6.2](/filings/0001736035-26-000016.md) | [6.1](/filings/0001736035-26-000016.md) | [5.9](/filings/0001736035-26-000016.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(90.4) d](/filings/0001736035-24-000035.md) | [(128) d](/filings/0001736035-26-000004.md) | [(396)](/filings/0001736035-25-000013.md) | [(709) d](/filings/0001736035-25-000018.md) | [(518) d](/filings/0001736035-25-000021.md) | [(904) d](/filings/0001736035-26-000004.md) | [425](/filings/0001736035-26-000010.md) | [(221) d](/filings/0001736035-26-000016.md) | [(433) d](/filings/0001736035-25-000021.md) | [(230) d](/filings/0001736035-26-000004.md) | [249](/filings/0001736035-26-000010.md) | [561 d](/filings/0001736035-26-000016.md) |
| Dividends paid | $m | [111 d](/filings/0001736035-24-000035.md) | [128 d](/filings/0001736035-26-000004.md) | [137](/filings/0001736035-25-000013.md) | [142 d](/filings/0001736035-25-000018.md) | [148 d](/filings/0001736035-25-000021.md) | [156 d](/filings/0001736035-26-000004.md) | [166](/filings/0001736035-26-000010.md) | [170 d](/filings/0001736035-26-000016.md) | [172 d](/filings/0001736035-25-000021.md) | [171 d](/filings/0001736035-26-000004.md) | [171](/filings/0001736035-26-000010.md) | [170 d](/filings/0001736035-26-000016.md) |
| Share repurchases | $m | [0.0 d](/filings/0001736035-23-000023.md) | [0.0 d](/filings/0001736035-25-000008.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [165](/filings/0001736035-23-000023.md) | [161](/filings/0001736035-24-000017.md) | [161](/filings/0001736035-24-000026.md) | [170](/filings/0001736035-24-000035.md) | [191](/filings/0001736035-25-000013.md) | [194](/filings/0001736035-25-000018.md) | [203](/filings/0001736035-25-000021.md) | [227](/filings/0001736035-26-000010.md) | [228](/filings/0001736035-26-000016.md) | [230](/filings/0001736035-25-000021.md) | [232](/filings/0001736035-26-000010.md) | [233](/filings/0001736035-26-000016.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 232,970,063 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001736035-26-000016.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.